当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析 - 现金流量表

智飞生物

(300122)

  

流通市值:284.28亿  总市值:481.15亿
流通股本:14.14亿   总股本:23.94亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金10,955,411,456.37,507,829,380.153,823,275,963.5936,933,180,960.41
  收到的税费返还406,133.03---
  收到其他与经营活动有关的现金169,973,323.0740,814,335.2723,179,926.73139,707,254.04
  经营活动现金流入小计11,125,790,912.47,548,643,715.423,846,455,890.3237,072,888,214.45
  购买商品、接受劳务支付的现金4,475,776,499.63,866,010,465.32,439,691,420.1935,476,050,758.77
  支付给职工以及为职工支付的现金1,358,618,838.08913,928,832.59513,121,152.571,809,219,214.87
  支付的各项税费339,675,547.02249,300,999.73103,390,316.692,070,230,637.59
  支付其他与经营活动有关的现金1,966,701,133.13955,028,729.31486,097,911.12,131,376,918.42
  经营活动现金流出小计8,140,772,017.835,984,269,026.933,542,300,800.5541,486,877,529.65
  经营活动产生的现金流量净额2,985,018,894.571,564,374,688.49304,155,089.77-4,413,989,315.2
二、投资活动产生的现金流量:
  收回投资收到的现金4,000,0004,000,0004,000,000-
  处置固定资产、无形资产和其他长期资产收回的现金净额6,835,079.96,817,645.66,364,945.64,759,655.97
  收到的其他与投资活动有关的现金76,938,380.01---
  投资活动现金流入小计87,773,459.9110,817,645.610,364,945.64,759,655.97
  购建固定资产、无形资产和其他长期资产支付的现金462,338,343.65259,397,490.09149,039,120.66930,343,067.65
  支付其他与投资活动有关的现金65,000,000---
  投资活动现金流出小计527,338,343.65259,397,490.09149,039,120.66930,343,067.65
  投资活动产生的现金流量净额-439,564,883.74-248,579,844.49-138,674,175.06-925,583,411.68
三、筹资活动产生的现金流量:
  取得借款收到的现金12,997,907,154.567,721,175,247.565,944,415,356.7214,738,177,057.94
  收到其他与筹资活动有关的现金5,543,763.983,459,226.759,6001,162,393.7
  筹资活动现金流入小计13,003,450,918.547,724,634,474.265,944,474,956.7214,739,339,451.64
  偿还债务支付的现金15,472,699,926.419,015,838,545.515,675,011,084.2610,198,541,303
  分配股利、利润或偿付利息支付的现金267,017,904.33146,234,36262,785,984.652,527,812,210.42
  支付其他与筹资活动有关的现金18,030,152.7812,888,115.984,233,575.99315,099,068.05
  筹资活动现金流出小计15,757,747,983.529,174,961,023.495,742,030,644.913,041,452,581.47
  筹资活动产生的现金流量净额-2,754,297,064.98-1,450,326,549.23202,444,311.821,697,886,870.17
四、汇率变动对现金及现金等价物的影响-407,575.19-443,332.42-122,611.31,252,023.78
五、现金及现金等价物净增加额-209,250,629.34-134,975,037.65367,802,615.23-3,640,433,832.93
  加:期初现金及现金等价物余额2,704,069,366.962,698,856,401.982,698,856,401.986,339,290,234.91
  期末现金及现金等价物余额2,494,818,737.622,563,881,364.333,066,659,017.212,698,856,401.98
补充资料:
  净利润--597,095,590.86-2,018,478,513.91
  资产减值准备-386,776,453.58-655,340,773.1
  固定资产和投资性房地产折旧-221,754,519.31-348,442,188.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-221,754,519.31-348,442,188.25
  无形资产摊销-22,464,701.99-27,346,564.24
  长期待摊费用摊销-8,447,401.05-16,235,199.86
  处置固定资产、无形资产和其他长期资产的损失--5,815,453.17--46,946.97
  固定资产报废损失-246,079.48-362,278.84
  公允价值变动损失--2,355,610.36--
  财务费用-156,744,146.88-141,498,348.61
  递延所得税--178,451,500.89--372,957,916.55
  其中:递延所得税资产减少--174,553,502.23--359,306,509.09
    递延所得税负债增加--3,897,998.66--13,651,407.46
  存货的减少-1,136,682,711.41--13,253,831,856.99
  经营性应收项目的减少-2,422,358,062.14-10,172,547,509.29
  经营性应付项目的增加--2,013,908,746.21--4,180,133,372.66
  现金的期末余额-2,563,881,364.33-2,698,856,401.98
  减:现金的期初余额-2,698,856,401.98-6,339,290,234.91
  现金及现金等价物的净增加额--134,975,037.65--3,640,433,832.93
公告日期2025-10-302025-08-192025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑